{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:28:10Z","timestamp":1794410890326,"version":"4.9.0"},"reference-count":43,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C6199\/A27327"],"award-info":[{"award-number":["C6199\/A27327"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013791","name":"Bowel Cancer UK","doi-asserted-by":"publisher","award":["18PG0010"],"award-info":[{"award-number":["18PG0010"]}],"id":[{"id":"10.13039\/100013791","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210804\/B\/18\/Z"],"award-info":[{"award-number":["210804\/B\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,12,2]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Germline\n                      <jats:italic>RNF43<\/jats:italic>\n                      mutations cause a dominantly inherited syndrome of colorectal cancer (CRC) and serrated polyps. However, these data originate from highly selected families.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      We assessed germline\n                      <jats:italic>RNF43<\/jats:italic>\n                      variants in patients more representative of the general population and compared these with somatic\n                      <jats:italic>RNF43<\/jats:italic>\n                      mutations in CRCs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We studied 49 823 CRC and\/or polyp cases from the CORGI study, 100\u2009000 Genomes (100kGP) and UK Biobank (UKB), alongside 165\u2009250 controls. Somatic mutations were analysed in 2722 CRCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Consistent with the literature, a germline loss-of-function\n                      <jats:italic>RNF43<\/jats:italic>\n                      variant (p.Thr158ProfsTer6) was found in a multigenerational CORGI family with early-onset CRC and serrated and\/or filiform polyps. However, while 23 CRC\/polyp cases and 47 controls from 100kGP or UKB had germline\n                      <jats:italic>RNF43<\/jats:italic>\n                      mutations, cases often lacked multiple polyps or a notable family history. Sometimes, CRCs developed independently of the germline\n                      <jats:italic>RNF43<\/jats:italic>\n                      mutation. In case-control analyses, germline\n                      <jats:italic>RNF43<\/jats:italic>\n                      variants were associated with CRC risk (OR=2.696, p=0.010), but penetrance was much greater for germline mutations in the N-terminal half of the gene. Germline C-terminal mutations conferred no increased CRC risk. However, somatic C-terminal mutations were pathogenic, perhaps because their relatively weak effects are supplemented by accompanying mutations in Wnt genes, including\n                      <jats:italic>ZNRF3<\/jats:italic>\n                      and a new driver,\n                      <jats:italic>SFRP4<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>RNF43<\/jats:italic>\n                      is a CRC predisposition gene, but risks are moderate, the reported polyposis phenotype is often absent and molecular phenocopies can occur. N-terminal germline\n                      <jats:italic>RNF43<\/jats:italic>\n                      variants confer higher risk, although weak effects of C-terminal variants cannot be excluded. Genetic testing and patient management should incorporate these factors.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-337030","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T18:25:21Z","timestamp":1766600721000},"page":"1353-1366","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison between germline and somatic loss-of-function\n                    <i>RNF43<\/i>\n                    mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis"],"prefix":"10.1136","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9670-2263","authenticated-orcid":false,"given":"Claire","family":"Palles","sequence":"first","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK"},{"name":"Birmingham Biomedical Research Centre, UK, National Institute for Health and Care Research, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Freeman-Mills","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Arbe-Barnes","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Feeley","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK"},{"name":"Scotland Cancer Centre, University of Edinburgh, Edinburgh, UK"},{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Chegwidden","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Curley","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Galavotti","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Woolley","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-8458","authenticated-orcid":false,"given":"Jeremy","family":"Cheadle","sequence":"additional","affiliation":[{"name":"School of Medicine, Cardiff University School of Medicine, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Mouradov","sequence":"additional","affiliation":[{"name":"Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia"},{"name":"Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9480-0786","authenticated-orcid":false,"given":"Oliver","family":"Sieber","sequence":"additional","affiliation":[{"name":"Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Salatino","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9962-9356","authenticated-orcid":false,"given":"Steve","family":"Thorn","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshita","family":"Goel","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fernandez-Tajes","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulochana","family":"Omwenga","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Biswas","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Maughan","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J","family":"Leedham","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK"},{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Translational Gastroenterology Unit, Univerity of Oxford Nuffield Department of Medicine, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"S:CORT Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"UK Colorectal Cancer Genomics Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CORGI Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"WGS500 Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor Hendrik","family":"Koelzer","sequence":"additional","affiliation":[{"name":"Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland"},{"name":"Computational and Translational Pathology Group, Department of Biomedical Engineering, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Mun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Changi General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Arnold","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8035-3700","authenticated-orcid":false,"given":"James Edward","family":"East","sequence":"additional","affiliation":[{"name":"Translational Gastroenterology Unit, Univerity of Oxford Nuffield Department of Medicine, Oxford, UK"},{"name":"NIHR Oxford Health Biomedical Research Centre, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3037-1470","authenticated-orcid":false,"given":"Ian","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"2026111106400871000_75.7.1353.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5307.1784"},{"key":"2026111106400871000_75.7.1353.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8259518"},{"key":"2026111106400871000_75.7.1353.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.8259519"},{"key":"2026111106400871000_75.7.1353.4","doi-asserted-by":"publisher","DOI":"10.1038\/nature11252"},{"key":"2026111106400871000_75.7.1353.5","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-023-01383-1","article-title":"Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker","volume":"28","author":"Xu","year":"2023","journal-title":"Eur J Med Res"},{"key":"2026111106400871000_75.7.1353.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2008.01.013"},{"key":"2026111106400871000_75.7.1353.7","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aac6757","article-title":"The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated \u03b2-catenin by sequestering TCF4 to the nuclear membrane","volume":"8","author":"Loregger","year":"2015","journal-title":"Sci Signal"},{"key":"2026111106400871000_75.7.1353.8","doi-asserted-by":"publisher","DOI":"10.1038\/nature11308"},{"key":"2026111106400871000_75.7.1353.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1232-5"},{"key":"2026111106400871000_75.7.1353.10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315733"},{"key":"2026111106400871000_75.7.1353.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81333-1"},{"key":"2026111106400871000_75.7.1353.12","doi-asserted-by":"publisher","DOI":"10.1177\/0004563215597944"},{"key":"2026111106400871000_75.7.1353.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.045"},{"key":"2026111106400871000_75.7.1353.14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/cge.14064","article-title":"RNF43 pathogenic Germline variant in a family with colorectal cancer","volume":"101","author":"Mikaeel","year":"2022","journal-title":"Clin Genet"},{"key":"2026111106400871000_75.7.1353.15","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1038\/hgv.2015.13","article-title":"A deleterious RNF43 germline mutation in a severely affected serrated polyposis kindred","volume":"2","author":"Taupin","year":"2015","journal-title":"Hum Genome Var"},{"key":"2026111106400871000_75.7.1353.16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311849"},{"key":"2026111106400871000_75.7.1353.17","doi-asserted-by":"crossref","unstructured":"Chan JM , Clendenning M , Joseland S , et al . Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family. Fam Cancer 2023;1\u201313. doi:10.1007\/S10689-023-00351-2\/FIGURES\/4","DOI":"10.1007\/s10689-023-00351-2"},{"key":"2026111106400871000_75.7.1353.18","doi-asserted-by":"crossref","DOI":"10.1007\/s10689-024-00428-6","article-title":"Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome","volume":"24","author":"Brinch","year":"2024","journal-title":"Fam Cancer"},{"key":"2026111106400871000_75.7.1353.19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/jgh.15791","article-title":"Germline variant testing in serrated polyposis syndrome","volume":"37","author":"Murphy","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"2026111106400871000_75.7.1353.20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113355","article-title":"Not All Wnt Activation Is Equal: Ligand-Dependent versus Ligand-Independent Wnt Activation in Colorectal Cancer","volume":"12","author":"Kleeman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026111106400871000_75.7.1353.21","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000923","article-title":"Low Yield of Genetic Testing in Serrated Polyposis Syndrome","volume":"16","author":"Upadhye","year":"2025","journal-title":"Clin Transl Gastroenterol"},{"key":"2026111106400871000_75.7.1353.22","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309675"},{"key":"2026111106400871000_75.7.1353.23","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa027","article-title":"Penetrance of Colorectal Cancer Among Mismatch Repair Gene Mutation Carriers: A Meta-Analysis","volume":"4","author":"Wang","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"2026111106400871000_75.7.1353.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54931-3","article-title":"The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis","volume":"9","author":"Tu","year":"2019","journal-title":"Sci Rep"},{"key":"2026111106400871000_75.7.1353.25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-024-07747-9","article-title":"The genomic landscape of 2,023 colorectal cancers","volume":"633","author":"Cornish","year":"2024","journal-title":"Nature New Biol"},{"key":"2026111106400871000_75.7.1353.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.027"},{"key":"2026111106400871000_75.7.1353.27","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00159-15"},{"key":"2026111106400871000_75.7.1353.28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12130"},{"key":"2026111106400871000_75.7.1353.29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-0957"},{"key":"2026111106400871000_75.7.1353.30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gendis.2023.01.030","article-title":"Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk","volume":"11","author":"Qin","year":"2024","journal-title":"Genes Dis"},{"key":"2026111106400871000_75.7.1353.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1118046108"},{"key":"2026111106400871000_75.7.1353.32","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2273"},{"key":"2026111106400871000_75.7.1353.33","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3127"},{"key":"2026111106400871000_75.7.1353.34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.941868","article-title":"Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction","volume":"12","author":"Lao","year":"2022","journal-title":"Front Oncol"},{"key":"2026111106400871000_75.7.1353.35","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12020623","article-title":"The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer","volume":"12","author":"Fang","year":"2023","journal-title":"J Clin Med"},{"key":"2026111106400871000_75.7.1353.36","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(02)02298-0"},{"key":"2026111106400871000_75.7.1353.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(09)60421-6"},{"key":"2026111106400871000_75.7.1353.38","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026111106400871000_75.7.1353.39","first-page":"516","article-title":"High prevalence of cancer-associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering","volume":"40","author":"Soussi","year":"2019","journal-title":"Hum Mutat"},{"key":"2026111106400871000_75.7.1353.40","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3999"},{"key":"2026111106400871000_75.7.1353.41","unstructured":"The national genomic research library v5.1. Genomics England; 2020."},{"key":"2026111106400871000_75.7.1353.42","doi-asserted-by":"crossref","unstructured":"Yuan K , Macintyre G , Liu W , et al . Ccube: a fast and robust method for estimating cancer cell fractions. bioRxiv [Preprint] 2018. doi:10.1101\/484402","DOI":"10.1101\/484402"},{"key":"2026111106400871000_75.7.1353.43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100782","article-title":"Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancer","volume":"296","author":"Zhong","year":"2021","journal-title":"J Biol Chem"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-337030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:42:09Z","timestamp":1794408129000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-337030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,9]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/gutjnl-2025-337030"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-337030","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}